[go: up one dir, main page]

AU2001278001A1 - Agonist of follicle stimulating hormone activity - Google Patents

Agonist of follicle stimulating hormone activity

Info

Publication number
AU2001278001A1
AU2001278001A1 AU2001278001A AU7800101A AU2001278001A1 AU 2001278001 A1 AU2001278001 A1 AU 2001278001A1 AU 2001278001 A AU2001278001 A AU 2001278001A AU 7800101 A AU7800101 A AU 7800101A AU 2001278001 A1 AU2001278001 A1 AU 2001278001A1
Authority
AU
Australia
Prior art keywords
agonist
stimulating hormone
follicle stimulating
hormone activity
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278001A
Other languages
English (en)
Inventor
Ronald W. Barrett
Ariamala Gopalsamy
Christopher P Holmes
Derek Maclean
Beatrice Ruhland
Randall A. Scheuerman
Jay E. Wrobel
Stephen D Yanofsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Affymax Researh Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymax Researh Institute Inc filed Critical Affymax Researh Institute Inc
Publication of AU2001278001A1 publication Critical patent/AU2001278001A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001278001A 2000-07-31 2001-07-24 Agonist of follicle stimulating hormone activity Abandoned AU2001278001A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/629,180 US6426357B1 (en) 1999-07-27 2000-07-31 Antagonists of follicle stimulating hormone activity
US09629180 2000-07-31
PCT/US2001/023386 WO2002009705A2 (fr) 2000-07-31 2001-07-24 Agoniste de l'activite de l'hormone folliculostimulante

Publications (1)

Publication Number Publication Date
AU2001278001A1 true AU2001278001A1 (en) 2002-02-13

Family

ID=24521931

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278001A Abandoned AU2001278001A1 (en) 2000-07-31 2001-07-24 Agonist of follicle stimulating hormone activity

Country Status (6)

Country Link
US (1) US6426357B1 (fr)
EP (1) EP1315489A1 (fr)
JP (1) JP2004505050A (fr)
AU (1) AU2001278001A1 (fr)
CA (1) CA2426297A1 (fr)
WO (1) WO2002009705A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399047T3 (es) * 2002-09-20 2013-03-25 Merck Serono Sa Derivados de piperazina y procedimiento de uso
EP1804824B1 (fr) 2004-09-29 2017-01-04 Icahn School of Medicine at Mount Sinai Compositions modulant la fsh et le recepteur de la fsh et methodes inhibant la resorption osseuse osteoclastique et les pertes osseuses de l'osteoporose
US7691848B2 (en) * 2005-03-02 2010-04-06 Wyeth Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists
JP2008540567A (ja) * 2005-05-12 2008-11-20 ワイス 卵胞刺激ホルモン受容体（ｆｓｈ−ｒ）アンタゴニストとしてのピロロベンゾジアゼピンおよびヘテロ環状カルボキサミド誘導体
JP2008540564A (ja) * 2005-05-12 2008-11-20 ワイス 卵胞刺激ホルモン受容体（ｆｓｈ−ｒ）アンタゴニストとしてのピロロベンゾジアゼピン、ヘテロアリール、アリールおよびシクロアルキルアミノケトン誘導体
JP2008543765A (ja) * 2005-06-09 2008-12-04 ワイス 卵胞刺激ホルモンレセプターアンタゴニストとしてのピロロベンゾジアゼピンピリジンカルボキサミドおよび誘導体
WO2007136776A2 (fr) * 2006-05-17 2007-11-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Ligands de pyrimidine de faible poids moléculaire destinés à moduler des récepteurs hormonaux
US20080221195A1 (en) * 2006-12-13 2008-09-11 Lars Wortmann 1,2-diarylacetylene derivatives of acyltryptophanols
EP1932831A1 (fr) * 2006-12-13 2008-06-18 Bayer Schering Pharma Aktiengesellschaft derivees de 1,2-diarylacetylen de acyltryptophanols
US20080207728A1 (en) * 2006-12-15 2008-08-28 Lars Wortmann Bicyclic acyltryptophanols
EP1956016A1 (fr) * 2006-12-15 2008-08-13 Bayer Schering Pharma Aktiengesellschaft Acyltryptophanols
WO2008071455A1 (fr) * 2006-12-15 2008-06-19 Bayer Schering Pharma Aktiengesellschaft Acyltryptophanols bicycliques
EP2090322A1 (fr) 2008-02-18 2009-08-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation de ligands du récepteur de la FSH pour le diagnostic et le traitement du cancer
US20100022497A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
US20100022494A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
US20100022487A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
US20110190201A1 (en) * 2008-07-24 2011-08-04 Searete Llc Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
JP6386382B2 (ja) 2012-02-08 2018-09-05 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 卵胞刺激ホルモン受容体のアゴニストとしての重水素化されたチアゾリジノン類似体
EP3950673A1 (fr) 2014-04-30 2022-02-09 Inspirna, Inc. Inhibiteurs de transport de créatine et leurs utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032588A (en) * 1989-12-08 1991-07-16 Abbott Laboratories Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids

Also Published As

Publication number Publication date
EP1315489A1 (fr) 2003-06-04
JP2004505050A (ja) 2004-02-19
CA2426297A1 (fr) 2002-02-07
US6426357B1 (en) 2002-07-30
WO2002009705A2 (fr) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2001278006A1 (en) Agonists of follicle stimulating hormone activity
AU2001278001A1 (en) Agonist of follicle stimulating hormone activity
AU2001231531A1 (en) Follicle stimulating hormones
AU2003207775A1 (en) Long-acting follicle stimulating hormone analogues and uses thereof
AU5963900A (en) Muteins of bilin-binding protein
AU7315700A (en) Melanin concentrating hormone antagonist
AU2002230860A1 (en) Skin desinfectant applicator
AU2002232544A1 (en) Skin disinfectant applicator
AU2002229087A1 (en) Skin disinfectant applicator
AU3867400A (en) Methods of using bioelastomers
AU4996300A (en) Method of electroporation-enhanced delivery of active agents
AU6934600A (en) Cd40 ligand and cd40 agonist compositions and methods of use
AU2001227815A1 (en) Chemically specific imaging of tissue
EP1153602A4 (fr) Preparations cutanees a usage externe
AU4134101A (en) Hormone receptor functional entities and methods of their use
AU2002302544A1 (en) Active ingredient combinations for hair-dyeing agents
AU7599200A (en) Fractal analysis of time varying data
EP1450860A4 (fr) Aliments pour animaux comprenant des principes actifs et procedes d'utilisation associes
AU4834900A (en) Antagonists of gonadotropin releasing hormone
AU2001272383A1 (en) Fungicidal combinations of active agents
WO2001091700A8 (fr) Composition et procede destine a ameliorer l'elasticite des tissus
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis
AU3212500A (en) Grooming device and method of using
AU3047299A (en) Methods of delivering glp-1
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations